Product Information
DILTIAZEM 24H ER(XR) 240 MG CP is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.5205 per EA under NDC 70436019302. Its NADAC has been published 182 times since Nov 30, 2022.
FDA first approved this application on Aug 8, 2022. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
240 mg/1
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436019302
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216304FDA Approved
8/8/2022
TE Code
AB2
On Market Since
9/5/2022
Pharmacological Classes
Price Statistics
The NADAC for DILTIAZEM 24H ER(XR) 240 MG CP has been published 182 times since Nov 30, 2022, and over the history we have for it it has declined 33.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5205 per EA |
|---|---|
| All-time high | $0.7780 (Dec 14, 2022) |
| All-time low | $0.4214 (Nov 20, 2024) |
| 52-week high | $0.6722 |
| 52-week low | $0.5090 |
| Median price | $0.6211 |
| Average price | $0.6056 |
| Largest weekly change | -35.1% (Nov 20, 2024) |
| Weeks tracked | 182 |
| Tracking since | Nov 30, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
-1.4%
1Y
-22.6%
3Y
-18.5%
5Y
N/A
All
-33.1%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 72% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DILTIAZEM 24H ER(XR) 240 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 24H ER(XR) 240 MG CP, manufactured by Slate Run Pharmaceuticals LLC, is $0.5205 per EA (NDC 70436019302), effective May 20, 2026.
How has the price of DILTIAZEM 24H ER(XR) 240 MG CP changed over time?
Over the history we have for it, the NADAC for DILTIAZEM 24H ER(XR) 240 MG CP has declined 33.1%. It has been tracked across 182 weekly CMS publications since Nov 30, 2022.
What are the highest and lowest recorded NADAC prices for DILTIAZEM 24H ER(XR) 240 MG CP?
Since Nov 30, 2022, the NADAC for DILTIAZEM 24H ER(XR) 240 MG CP has ranged from a low of $0.4214 (Nov 20, 2024) to a high of $0.7780 (Dec 14, 2022), with a median of $0.6211 per EA.
Are there cheaper alternatives to DILTIAZEM 24H ER(XR) 240 MG CP?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DILTIAZEM 24HR ER 240 MG CAP, is $0.1482 per EA — about 72% below DILTIAZEM 24H ER(XR) 240 MG CP.
Who manufactures DILTIAZEM 24H ER(XR) 240 MG CP?
DILTIAZEM 24H ER(XR) 240 MG CP (NDC 70436019302) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.